Juvenile Protective Factors and Their Effects on Aging (R03) | Apply Online

Opportunity Summary:

The NIH funding opportunity PAR 14-022, titled "Juvenile Protective Factors and Their Effects on Aging (R03)," supports small, early-stage pilot or feasibility research projects aimed at understanding whether certain biologic advantages present during childhood and adolescence help protect the body in ways that might influence health and aging later in life. The central idea is that some physiological factors help maintain or boost function during specific periods of postnatal development, but then naturally decline or disappear as a person (or animal) moves through key maturation transitions. The program is designed to help researchers identify these potential "juvenile protective factors," test whether they actually affect aging-related outcomes, and explore whether there are practical or clinical implications for preserving or adjusting these factors in adulthood.

The FOA lays out three main types of studies it wants to encourage. First are descriptive studies, which focus on identifying candidate juvenile protective factors and characterizing how they change across developmental stages. This could involve mapping patterns of hormones, growth factors, immune features, metabolic regulators, tissue repair responses, or other physiologic pathways that are strong in earlier life and then diminish with maturation. Second are experimental studies, which are meant to go beyond description and directly test hypotheses about whether a given factor has a causal role in shaping later-life aging trajectories or aging-related functional decline. Third are translational studies, which explore the potential risks and benefits of trying to maintain juvenile-like levels of these factors in adult life, or alternatively modulating them in some targeted way. The translational emphasis is important because it signals interest not only in mechanisms, but also in whether manipulating these factors could be beneficial, harmful, or context-dependent when applied outside the juvenile period.

A defining feature of this announcement is its requirement for comparisons across postnatal developmental stages, or comparisons of pre- versus post-maturational changes, specifically to detect factors that are present or protective earlier and then fade with developmental transitions. Examples of transitions the FOA highlights include infancy, adiposity rebound (a well-known shift in childhood body composition trajectory), adrenarche (the developmental phase involving adrenal androgen production), puberty, and growth cessation. In practice, this means competitive applications would be expected to build the study design around stage-to-stage comparisons rather than treating "youth" as a single uniform period. The FOA is essentially asking investigators to leverage biology that changes across these milestones as a natural framework for discovering protective mechanisms and understanding their long-term consequences.

The mechanism is an R03, which is NIH's small grant mechanism typically used for pilot work, feasibility testing, proof-of-concept experiments, and early development of new directions that may later justify a larger R01 or similar award. The award ceiling listed is $200,000, and there is no cost sharing or matching requirement. The announcement allows pilot studies in several research contexts, including in vitro models, laboratory animal models, and human studies, which gives applicants flexibility to choose the most appropriate system for identifying and testing these factors. Because the FOA is about maturation-linked changes and their relationship to aging, strong applications would usually be expected to connect developmental biology to later-life functional outcomes in a way that is measurable and logically tied to aging processes.

In terms of administrative details, the opportunity is categorized as a discretionary grant under NIH, within the broad activity areas of health, income security, and social services. It is associated with CFDA numbers 93.865 (Child Health and Human Development Extramural Research) and 93.866 (Aging Research), reflecting its cross-cutting nature between developmental science and aging biology. The FOA was posted and created on December 11, 2013, and the final closing date was July 16, 2016, with the archive date of August 16, 2016, meaning it is no longer active but remains relevant as a reference point for the types of studies NIH has sought in this space.

Eligibility is broad and includes many U.S. organization types such as public and private institutions of higher education, nonprofits with and without 501(c)(3) status, for-profit entities (including small businesses and other for-profits), state and local governments, independent school districts, and tribal governments and tribal organizations. The eligibility language also explicitly includes a range of specialized institution categories such as HBCUs, Hispanic-serving institutions, AANAPISIs, Alaska Native and Native Hawaiian-serving institutions, tribally controlled colleges and universities, faith-based or community-based organizations, and regional organizations. Importantly, non-U.S. entities are also eligible: foreign organizations and foreign institutions may apply, non-U.S. components of U.S. organizations are eligible, and foreign components (as defined by NIH policy) are allowed. This reflects NIH's willingness to support scientifically strong work on developmental protective factors and aging even when the research team or setting is outside the United States.

Overall, this FOA is best understood as a targeted call for early-stage projects that treat postnatal development as a window for discovering biological factors that may confer resilience, enhanced repair capacity, or other protections that could shape aging. It invites applicants to identify what those factors might be, establish whether they matter for aging outcomes, and begin exploring whether maintaining or adjusting them later in life could become a plausible strategy, while also acknowledging that altering developmental-stage biology in adults could carry risks that need careful evaluation.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health Income Security and Social Services

Next opportunity: Basic Mechanisms of Brain Development for Substance Use and Dependence (R01)

Previous opportunity: SIGMA

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 14 022

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 14 022) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 14 022", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.